Skip to main content Accessibility help
×
Home
  • Print publication year: 2016
  • Online publication date: July 2016

4 - Hypertensive disorders in pregnancy

1.National Institute for Health and Care Excellence (NICE). Hypertension in Pregnancy: the Management of Hypertensive Disorders during Pregnancy. NICE Clinical Guideline CG107. London: NICE, 2010.
2.Knight, M, Tuffnell, D, Kenyon, S, et al. (eds.) on behalf of MBRRACE-UK. Saving Lives, Improving Mothers’ Care: Surveillance of Maternal Deaths in the UK 2011–13 and Lessons Learned to Inform Maternity Care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–13. Oxford: National Perinatal Epidemiology Unit, 2015.
3.Knight, M. Eclampsia in the United Kingdom 2005. BJOG 2007; 114: 1072–8.
4.Centre for Maternal and Child Enquiries (CMACE). Perinatal Mortality 2009: United Kingdom. London: CMACE, 2011.
5.Magee, LA, von Dadelszen, P, Rey, E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 2015; 372: 407–17.
6.Walker, JJ. Daycare assessment and hypertensive disorders of pregnancy. Fetal Matern Med Rev 1994; 6: 5770.
7.Tuffnell, DJ, Lilford, RJ, Buchan, PC, et al. Randomised controlled trial of day care for hypertension in pregnancy. Lancet 1992; 339: 224–7.
8.Twaddle, S, Harper, V. An economic evaluation of daycare in the management of hypertension in pregnancy Br J Obstet Gynaecol 1992; 99: 459–63.
9.Action on Pre-eclampsia. Pre-eclampsia community (PRECOG) guidelines. http://action-on-pre-eclampsia.org.uk/professional-area/precog (accessed 3 October 2015).
10.Vijgen, SM, Koopmans, CM, Opmeer, BC, et al. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial). BJOG 2010; 117: 1577–85.
11.Smith, RA, Kenny, LC. Current thoughts on the pathogenesis of pre-eclampsia. The Obstetrician & Gynaecologist 2006; 8: 713.
12.Cnossen, JS, Morris, RK, ter Riet, G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. Can Med Assoc J 2008; 178: 701–11. doi:10.1503/cmaj.070430.
13.Duley, L, Henderson-Smart, DJ, Meher, S, King, JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007; (2): CD004659.
14.Hofmeyr, GJ, Lawrie, TA, Atallah, AN, Duley, L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2010; (8): CD001059.
15.Nelson-Piercy, C. Normal laboratory values in pregnancy/non-pregnancy. In Handbook of Obstetric Medicine, 4th edn. London: Informa Healthcare, 2010; p. 273.
16.Altman, D, Carroli, G, Duley, L, et al.; Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 359: 1877–90.
17.Bramham, K, Nelson-Piercy, C, Brown, MJ, Chappell, LC. Postpartum management of hypertension. BMJ 2013; 346: f894.